Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Comparative Molecular Life History of Spontaneous Canine and Human Gliomas.

Amin SB, Anderson KJ, Boudreau CE, Martinez-Ledesma E, Kocakavuk E, Johnson KC, Barthel FP, Varn FS, Kassab C, Ling X, Kim H, Barter M, Lau CC, Ngan CY, Chapman M, Koehler JW, Long JP, Miller AD, Miller CR, Porter BF, Rissi DR, Mazcko C, LeBlanc AK, Dickinson PJ, Packer RA, Taylor AR, Rossmeisl JH Jr, Woolard KD, Heimberger AB, Levine JM, Verhaak RGW.

Cancer Cell. 2020 Feb 10;37(2):243-257.e7. doi: 10.1016/j.ccell.2020.01.004.

PMID:
32049048
2.

Clinicopathological characteristics of histiocytic sarcoma affecting the central nervous system in dogs.

Toyoda I, Vernau W, Sturges BK, Vernau KM, Rossmeisl J, Zimmerman K, Crowe CM, Woolard K, Giuffrida M, Higgins RJ, Dickinson PJ.

J Vet Intern Med. 2020 Jan 10. doi: 10.1111/jvim.15673. [Epub ahead of print]

3.

DNA vaccination before conception protects Zika virus-exposed pregnant macaques against prolonged viremia and improves fetal outcomes.

Van Rompay KKA, Keesler RI, Ardeshir A, Watanabe J, Usachenko J, Singapuri A, Cruzen C, Bliss-Moreau E, Murphy AM, Yee JL, Webster H, Dennis M, Singh T, Heimsath H, Lemos D, Stuart J, Morabito KM, Foreman BM, Burgomaster KE, Noe AT, Dowd KA, Ball E, Woolard K, Presicce P, Kallapur SG, Permar SR, Foulds KE, Coffey LL, Pierson TC, Graham BS.

Sci Transl Med. 2019 Dec 18;11(523). pii: eaay2736. doi: 10.1126/scitranslmed.aay2736.

PMID:
31852797
4.

Ganglioglioma of the Right Cerebrothalamus in a 7-Year-Old Quarter Horse Cross Gelding.

Easton-Jones C, Woolard K, Mohr FC, Roy MA, Aleman M.

Front Vet Sci. 2019 Oct 22;6:356. doi: 10.3389/fvets.2019.00356. eCollection 2019.

5.

Cetylpyridinium chloride is a potent AMP-activated kinase (AMPK) inducer and has therapeutic potential in cancer.

Allen SA, Datta S, Sandoval J, Tomilov A, Sears T, Woolard K, Angelastro JM, Cortopassi GA.

Mitochondrion. 2020 Jan;50:19-24. doi: 10.1016/j.mito.2019.09.009. Epub 2019 Oct 22.

PMID:
31654752
6.

Clinical outcomes, ultrastructure and immunohistochemical features of canine high-grade olfactory neuroblastoma.

Church ME, Veluvolu SM, Durham AC, Woolard KD.

Vet Comp Oncol. 2019 Dec;17(4):578-584. doi: 10.1111/vco.12512. Epub 2019 Jul 1.

PMID:
31177641
7.

Nanomedicine for Spontaneous Brain Tumors: A Companion Clinical Trial.

Arami H, Patel CB, Madsen SJ, Dickinson PJ, Davis RM, Zeng Y, Sturges BK, Woolard KD, Habte FG, Akin D, Sinclair R, Gambhir SS.

ACS Nano. 2019 Mar 26;13(3):2858-2869. doi: 10.1021/acsnano.8b04406. Epub 2019 Feb 4.

8.

Author Correction: Cancer in wildlife: patterns of emergence.

Pesavento PA, Agnew D, Keel MK, Woolard KD.

Nat Rev Cancer. 2019 May;19(5):299. doi: 10.1038/s41568-019-0113-0.

9.

Metastatic immune infiltrates correlate with those of the primary tumour in canine osteosarcoma.

Withers SS, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Burton JH, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB.

Vet Comp Oncol. 2019 Sep;17(3):242-252. doi: 10.1111/vco.12459. Epub 2019 Apr 8.

PMID:
30684301
10.

A genetically engineered microRNA-34a prodrug demonstrates anti-tumor activity in a canine model of osteosarcoma.

Alegre F, Ormonde AR, Snider KM, Woolard K, Yu AM, Wittenburg LA.

PLoS One. 2018 Dec 31;13(12):e0209941. doi: 10.1371/journal.pone.0209941. eCollection 2018.

11.

A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma.

Koehler JW, Miller AD, Miller CR, Porter B, Aldape K, Beck J, Brat D, Cornax I, Corps K, Frank C, Giannini C, Horbinski C, Huse JT, O'Sullivan MG, Rissi DR, Mark Simpson R, Woolard K, Shih JH, Mazcko C, Gilbert MR, LeBlanc AK.

J Neuropathol Exp Neurol. 2018 Nov 1;77(11):1039-1054. doi: 10.1093/jnen/nly085.

12.

Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma.

Withers SS, Skorupski KA, York D, Choi JW, Woolard KD, Laufer-Amorim R, Sparger EE, Rodriguez CO, McSorley SJ, Monjazeb AM, Murphy WJ, Canter RJ, Rebhun RB.

Vet Comp Oncol. 2019 Mar;17(1):49-60. doi: 10.1111/vco.12444. Epub 2018 Sep 19.

PMID:
30156029
13.

Cancer in wildlife: patterns of emergence.

Pesavento PA, Agnew D, Keel MK, Woolard KD.

Nat Rev Cancer. 2018 Oct;18(10):646-661. doi: 10.1038/s41568-018-0045-0. Review. Erratum in: Nat Rev Cancer. 2019 May;19(5):299.

PMID:
30116020
14.

Intraamniotic Zika virus inoculation of pregnant rhesus macaques produces fetal neurologic disease.

Coffey LL, Keesler RI, Pesavento PA, Woolard K, Singapuri A, Watanabe J, Cruzen C, Christe KL, Usachenko J, Yee J, Heng VA, Bliss-Moreau E, Reader JR, von Morgenland W, Gibbons AM, Jackson K, Ardeshir A, Heimsath H, Permar S, Senthamaraikannan P, Presicce P, Kallapur SG, Linnen JM, Gao K, Orr R, MacGill T, McClure M, McFarland R, Morrison JH, Van Rompay KKA.

Nat Commun. 2018 Jun 20;9(1):2414. doi: 10.1038/s41467-018-04777-6.

15.

Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.

Barberini DJ, Aleman M, Aristizabal F, Spriet M, Clark KC, Walker NJ, Galuppo LD, Amorim RM, Woolard KD, Borjesson DL.

Stem Cell Res Ther. 2018 Apr 10;9(1):96. doi: 10.1186/s13287-018-0849-6.

16.

Cerebellar Abiotrophy Across Domestic Species.

Scott EY, Woolard KD, Finno CJ, Murray JD.

Cerebellum. 2018 Jun;17(3):372-379. doi: 10.1007/s12311-017-0914-1. Review.

17.

Variation in MUTYH expression in Arabian horses with Cerebellar Abiotrophy.

Scott EY, Woolard KD, Finno CJ, Penedo MCT, Murray JD.

Brain Res. 2018 Jan 1;1678:330-336. doi: 10.1016/j.brainres.2017.10.034. Epub 2017 Nov 2.

18.

Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses.

Textor JA, Clark KC, Walker NJ, Aristizobal FA, Kol A, LeJeune SS, Bledsoe A, Davidyan A, Gray SN, Bohannon-Worsley LK, Woolard KD, Borjesson DL.

Stem Cells Transl Med. 2018 Jan;7(1):98-108. doi: 10.1002/sctm.17-0071. Epub 2017 Oct 24.

19.

Detailed longitudinal sampling of glioma stem cells in situ reveals Chr7 gain and Chr10 loss as repeated events in primary tumor formation and recurrence.

Baysan M, Woolard K, Cam MC, Zhang W, Song H, Kotliarova S, Balamatsias D, Linkous A, Ahn S, Walling J, Belova GI, Fine HA.

Int J Cancer. 2017 Nov 15;141(10):2002-2013. doi: 10.1002/ijc.30887. Epub 2017 Aug 21.

20.

Evaluation of P16 expression in canine appendicular osteosarcoma.

Murphy BG, Mok MY, York D, Rebhun R, Woolard KD, Hillman C, Dickinson P, Skorupski K.

BMC Vet Res. 2017 Jun 20;13(1):189. doi: 10.1186/s12917-017-1113-5.

21.

BRD4 is associated with raccoon polyomavirus genome and mediates viral gene transcription and maintenance of a stem cell state in neuroglial tumour cells.

Church ME, Estrada M, Leutenegger CM, Dela Cruz FN, Pesavento PA, Woolard KD.

J Gen Virol. 2016 Nov;97(11):2939-2948. doi: 10.1099/jgv.0.000594. Epub 2016 Sep 6.

22.

Production of a recombinant capsid protein VP1 from a newly described polyomavirus (RacPyV) for downstream use in virus characterization.

Church ME, Dela Cruz FN, Kim K, Persiani M, Woods LW, Pesavento PA, Woolard KD.

Data Brief. 2016 Feb 9;7:60-5. doi: 10.1016/j.dib.2016.01.070. eCollection 2016 Jun.

23.

Polyomavirus and Naturally Occuring Neuroglial Tumors in Raccoons (Procyon Lotor).

Pesavento PA, Brostoff T, Church ME, Dela Cruz FN Jr, Woolard KD.

ILAR J. 2016;56(3):297-305. doi: 10.1093/ilar/ilv036.

PMID:
26912716
24.

Exposure to raccoon polyomavirus (RacPyV) in free-ranging North American raccoons (Procyon lotor).

Church ME, Dela Cruz FN Jr, Estrada M, Leutenegger CM, Pesavento PA, Woolard KD.

Virology. 2016 Feb;489:292-9. doi: 10.1016/j.virol.2015.11.033. Epub 2016 Jan 21.

25.

Rapid tumor induction in zebrafish by TALEN-mediated somatic inactivation of the retinoblastoma1 tumor suppressor rb1.

Solin SL, Shive HR, Woolard KD, Essner JJ, McGrail M.

Sci Rep. 2015 Sep 8;5:13745. doi: 10.1038/srep13745.

26.

Characterization of the temporomandibular joint of the harbour porpoise (Phocoena phocoena) and Risso's dolphin (Grampus griseus).

McDonald M, Vapniarsky-Arzi N, Verstraete FJ, Staszyk C, Leale DM, Woolard KD, Arzi B.

Arch Oral Biol. 2015 Apr;60(4):582-92. doi: 10.1016/j.archoralbio.2015.01.005. Epub 2015 Jan 9.

PMID:
25617743
27.

Identification of a polyomavirus microRNA highly expressed in tumors.

Chen CJ, Cox JE, Azarm KD, Wylie KN, Woolard KD, Pesavento PA, Sullivan CS.

Virology. 2015 Feb;476:43-53. doi: 10.1016/j.virol.2014.11.021. Epub 2014 Dec 13. Erratum in: Virology. 2015 Aug;482:269.

28.

Identification of molecular pathways facilitating glioma cell invasion in situ.

Nevo I, Woolard K, Cam M, Li A, Webster JD, Kotliarov Y, Kim HS, Ahn S, Walling J, Kotliarova S, Belova G, Song H, Bailey R, Zhang W, Fine HA.

PLoS One. 2014 Nov 3;9(11):e111783. doi: 10.1371/journal.pone.0111783. eCollection 2014.

29.

The raccoon polyomavirus genome and tumor antigen transcription are stable and abundant in neuroglial tumors.

Brostoff T, Dela Cruz FN Jr, Church ME, Woolard KD, Pesavento PA.

J Virol. 2014 Nov;88(21):12816-24. doi: 10.1128/JVI.01912-14. Epub 2014 Aug 27.

30.

Micro-environment causes reversible changes in DNA methylation and mRNA expression profiles in patient-derived glioma stem cells.

Baysan M, Woolard K, Bozdag S, Riddick G, Kotliarova S, Cam MC, Belova GI, Ahn S, Zhang W, Song H, Walling J, Stevenson H, Meltzer P, Fine HA.

PLoS One. 2014 Apr 11;9(4):e94045. doi: 10.1371/journal.pone.0094045. eCollection 2014.

31.

ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state.

Chudnovsky Y, Kim D, Zheng S, Whyte WA, Bansal M, Bray MA, Gopal S, Theisen MA, Bilodeau S, Thiru P, Muffat J, Yilmaz OH, Mitalipova M, Woolard K, Lee J, Nishimura R, Sakata N, Fine HA, Carpenter AE, Silver SJ, Verhaak RG, Califano A, Young RA, Ligon KL, Mellinghoff IK, Root DE, Sabatini DM, Hahn WC, Chheda MG.

Cell Rep. 2014 Jan 30;6(2):313-24. doi: 10.1016/j.celrep.2013.12.032. Epub 2014 Jan 16.

32.

Histone demethylase Jumonji D3 (JMJD3) as a tumor suppressor by regulating p53 protein nuclear stabilization.

Ene CI, Edwards L, Riddick G, Baysan M, Woolard K, Kotliarova S, Lai C, Belova G, Cam M, Walling J, Zhou M, Stevenson H, Kim HS, Killian K, Veenstra T, Bailey R, Song H, Zhang W, Fine HA.

PLoS One. 2012;7(12):e51407. doi: 10.1371/journal.pone.0051407. Epub 2012 Dec 7.

33.

Gliomagenesis arising from Pten- and Ink4a/Arf-deficient neural progenitor cells is mediated by the p53-Fbxw7/Cdc4 pathway, which controls c-Myc.

Kim HS, Woolard K, Lai C, Bauer PO, Maric D, Song H, Li A, Kotliarova S, Zhang W, Fine HA.

Cancer Res. 2012 Nov 15;72(22):6065-75. doi: 10.1158/0008-5472.CAN-12-2594. Epub 2012 Sep 17.

34.

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.

Morgan RA, Johnson LA, Davis JL, Zheng Z, Woolard KD, Reap EA, Feldman SA, Chinnasamy N, Kuan CT, Song H, Zhang W, Fine HA, Rosenberg SA.

Hum Gene Ther. 2012 Oct;23(10):1043-53. doi: 10.1089/hum.2012.041. Epub 2012 Sep 24.

35.

Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.

Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G, Jensen RT, Zhang W, Fine HA.

J Natl Cancer Inst. 2011 Aug 3;103(15):1162-78. doi: 10.1093/jnci/djr224. Epub 2011 Jul 19.

36.

Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.

Wei BR, Hoover SB, Ross MM, Zhou W, Meani F, Edwards JB, Spehalski EI, Risinger JI, Alvord WG, QuiƱones OA, Belluco C, Martella L, Campagnutta E, Ravaggi A, Dai RM, Goldsmith PK, Woolard KD, Pecorelli S, Liotta LA, Petricoin EF, Simpson RM.

PLoS One. 2009 Oct 30;4(10):e7670. doi: 10.1371/journal.pone.0007670.

37.

Genetic evidence for the role of Erk activation in a lymphoproliferative disease of mice.

Miyaji M, Kortum RL, Surana R, Li W, Woolard KD, Simpson RM, Samelson LE, Sommers CL.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14502-7. doi: 10.1073/pnas.0903894106. Epub 2009 Aug 10.

38.

Glioma stem cells: better flat than round.

Woolard K, Fine HA.

Cell Stem Cell. 2009 Jun 5;4(6):466-7. doi: 10.1016/j.stem.2009.05.013.

39.

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

Son MJ, Woolard K, Nam DH, Lee J, Fine HA.

Cell Stem Cell. 2009 May 8;4(5):440-52. doi: 10.1016/j.stem.2009.03.003.

40.

Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells.

Lee J, Son MJ, Woolard K, Donin NM, Li A, Cheng CH, Kotliarova S, Kotliarov Y, Walling J, Ahn S, Kim M, Totonchy M, Cusack T, Ene C, Ma H, Su Q, Zenklusen JC, Zhang W, Maric D, Fine HA.

Cancer Cell. 2008 Jan;13(1):69-80. doi: 10.1016/j.ccr.2007.12.005.

41.

Metallophilic interactions in iodido(2,2':6',2''-terpyridine)platinum(II) diiodidoaurate(I).

Angle CS, Woolard KJ, Kahn MI, Golen JA, Rheingold AL, Doerrer LH.

Acta Crystallogr C. 2007 Jun;63(Pt 6):m231-4. Epub 2007 May 11.

PMID:
17551175
42.

Clearance of a dermal Huffmanela sp. in a sandbar shark (Carcharhinus plumbeus) using levamisole.

MacLean RA, Fatzinger MH, Woolard KD, Harms CA.

Dis Aquat Organ. 2006 Nov 21;73(1):83-8.

43.

The commonalities quest: toward a theory of "problem behavior".

Agar MH, Underwood C, Woolard K.

J Psychoactive Drugs. 1981 Oct-Dec;13(4):333-43. No abstract available.

PMID:
7338743

Supplemental Content

Loading ...
Support Center